글로벌 세포 용해 및 분리 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

세포 용해 및 분리 시장 분석

세포 용해 및 분리 시장은 생명공학 및 분자 연구의 발전으로 인해 상당한 성장을 경험하고 있습니다. 이 분야의 발전에는 더 높은 효율성과 세포 구성 요소의 더 나은 보존을 제공하는 혁신적인 세포 용해 기술의 도입이 포함됩니다. 이제 기업들은 다양한 연구 워크플로에 원활하게 통합되는 보다 정교하고 자동화된 시스템을 개발하는 데 주력하고 있습니다. 예를 들어, 마이크로유체 장치와 음향 용해 시스템의 도입은 연구자들이 세포 샘플을 처리하고 처리하는 방식에 혁명을 일으켜 용해 프로세스를 정확하게 제어하고 샘플 손실을 최소화했습니다. 또한 시약 제형의 발전과 새로운 소모품의 개발로 세포 용해 및 분리 기술의 다양성과 효과가 향상되고 있습니다. 이 시장은 또한 제약 및 생명공학 기업의 연구 개발에 대한 투자 증가와 개인화된 의학 및 재생 치료에 대한 강조가 커짐에 따라 혜택을 받고 있습니다.

세포 용해 및 분리 시장 규모

글로벌 세포 용해 및 분리 시장 규모는 2023년에 48억 7천만 달러로 평가되었으며, 2031년까지 96억 4천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 8.90%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

세포 용해 및 분리 시장 동향

“ 효소 세포 분리 방법의 채택 증가”

세포 용해 및 분리 시장은 세포 생물학 및 재생 의학 연구 증가에 힘입어 강력한 성장을 경험하고 있습니다. 시장에서 주목할 만한 추세는 기계적 방법에 비해 세포를 더 정확하고 부드럽게 추출할 수 있는 효소적 세포 분리 방법의 채택이 증가하고 있다는 것입니다. 예를 들어, Thermo Fisher Scientific과 같은 회사는 분리 중 세포 손상을 최소화하여 세포 생존력과 수율을 개선하는 TrypLE Express와 같은 고급 효소 기반 솔루션을 개발했습니다. 이러한 추세는 줄기 세포 연구 및 유전자 치료와 같은 응용 분야에서 특히 중요한데, 이러한 응용 분야에서는 세포 무결성을 유지하는 것이 성공적인 결과에 필수적입니다. 효소적 방법으로의 전환은 세포 분리 프로세스의 효율성을 높이고 개인화된 의학 및 세포 치료의 발전을 지원하고 있습니다. 연구자와 임상의가 세포 조작을 위한 더 효과적이고 부드러운 기술을 추구함에 따라 혁신적인 세포 용해 및 분리 솔루션에 대한 수요가 계속 증가하여 시장 확장과 기술 발전을 촉진하고 있습니다.

보고 범위 및 세포 용해 및 분리 시장 세분화 

Cell Lysis and Dissociation Market Definition

Cell lysis and dissociation are laboratory techniques used to break down cellular structures and separate cells from their surroundings for further analysis or experimentation. Cell lysis involves disrupting the cell membrane to release intracellular components, such as proteins, nucleic acids, and organelles. It can be achieved through various methods, including mechanical, chemical, or enzymatic processes. Cell dissociation, on the other hand, specifically refers to the process of separating individual cells from each other, often after they have been cultured or grown in a tissue. Dissociation can be done using enzymatic treatments that break down cell-cell adhesion molecules, allowing for the isolation of single cells or cell populations. Together, these techniques are essential for applications in research, diagnostics, and therapeutic development, enabling detailed study of cellular functions and interactions.

Cell Lysis and Dissociation Market Dynamics

Drivers

• Surge in Biotechnology and Pharmaceutical Research

The surge in biotechnology and pharmaceutical research is significantly driving the demand for advanced cell lysis and dissociation technologies, as these tools are integral to several key applications. For instance, in drug discovery, precise cell lysis is essential for extracting cellular proteins and nucleic acids, which are crucial for identifying potential drug targets and evaluating drug efficacy. In cell-based assays, such as those used in high-throughput screening, effective cell lysis ensures that researchers can accurately measure cellular responses to various compounds. Additionally, in genomics research, technologies such as next-generation sequencing rely on efficient cell dissociation to isolate high-quality DNA or RNA from complex samples. Thermo Fisher Scientific and Bio-Rad Laboratories have developed advanced systems that cater to such needs, providing researchers with the tools required to advance their work in drug discovery and genomics. As investments continue to flow into these research areas, the demand for cutting-edge cell lysis and dissociation technologies is expected to grow, further driving market expansion.

• Expansion of Cell-Based Therapies

The expansion of cell-based therapies, such as stem cell therapy and CAR-T cell therapy, underscores the need for precise cell lysis and dissociation methods to effectively prepare and analyze therapeutic cells. In CAR-T cell therapy, the process involves isolating T cells from a patient's blood, genetically modifying them to target cancer cells, and then expanding these modified cells. Efficient cell dissociation is crucial for obtaining a high yield of viable T cells from the patient's blood and for ensuring the successful genetic modification of these cells. For instance, the use of the Miltenyi Biotec’s GentleMACS Dissociator, which provides controlled, gentle dissociation of cell aggregates without compromising cell viability. Such precision is vital for maintaining the integrity of the cells and optimizing their therapeutic efficacy. As cell-based therapies advance, the demand for accurate and effective lysis and dissociation techniques continues to grow, driving innovations in these processes.

Opportunities

• Increasing Investments in Biopharmaceutical R&D

Biopharmaceutical development is a major growth driver for the cell lysis and dissociation market, fueled by rising investments in research and development. For instance, according to the International Federation Of Pharmaceutical Manufacturers and Associations, the research-based biopharmaceutical industry is estimated to have spent USD 198 billion globally on biopharmaceutical R&D in 2020. Such heightened investment underscores the need for advanced cell lysis technologies that can efficiently process and analyze cell samples. In particular, cell lysis plays a critical role in gene and cell therapy, where accurate and high-yield extraction of nucleic acids and proteins from cells is essential for developing effective treatments. Technologies such as high-throughput cell lysis systems and automated platforms are increasingly sought after to meet the demands of large-scale biopharmaceutical research and ensure the successful development of novel therapies. Growing emphasis on advanced cell processing solutions highlights the market's potential and underscores the importance of innovation in meeting the needs of the evolving biopharmaceutical landscape.

• Development of Customized Reagents and Consumables

The development of customized reagents and consumables represents a significant opportunity in the cell lysis and dissociation market, as it directly addresses specific research needs and improves process efficiency. For instance, in 2022, Thermo Fisher Scientific introduced a line of custom-designed lysis buffers tailored for challenging cell types, including primary human cells and difficult-to-lyse microbial cells. These specialized reagents have demonstrated notable improvements in the yield and purity of extracted proteins and nucleic acids, which enhances the reliability of research outcomes. Such trend reflects the growing demand for precise solutions in applications spanning genomics and proteomics. As research becomes more specialized, offering reagents and consumables that cater to unique cell types or experimental conditions provides a competitive advantage and drives progress in scientific discovery.

Restraints/Challenges

• Procedural Cell Damage

Minimizing cell damage during the lysis and dissociation processes is a significant challenge, as harsh chemical or mechanical methods can compromise cell viability and affect the quality of downstream applications. For instance, using high concentrations of detergents or aggressive mechanical homogenization can lead to excessive cell disruption, resulting in the release of intracellular components that can interfere with subsequent analyses. An illustrative case is the use of traditional mechanical tissue homogenizers for cell lysis, which, while effective at breaking down cell walls, often cause shear stress that damages sensitive cells and their components. Such damage can impact the accuracy of downstream assays such as protein quantification or genomic analysis. Consequently impeding the market growth.

• Optimizing Protocols for Cell Lysis and Dissociation

Optimizing protocols for cell lysis and dissociation presents a challenge due to the need for specific approaches tailored to different cell types and experimental conditions. For instance, while trypsin is effective for detaching adherent cell lines such as HEK293 cells, it is less suitable for primary fibroblasts, which may require a combination of collagenase and dispase for optimal results. Researchers must navigate the complexity of developing and standardizing these protocols to ensure consistency and effectiveness across various applications. This process involves significant trial and error, rigorous validation, and adaptation to specific experimental requirements, making it both time-consuming and resource-intensive. Consequently, achieving reliable and consistent results across diverse cell types and experimental conditions remains a major challenge in cell biology research.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Cell Lysis and Dissociation Market Scope

The market is segmented on the basis of product type, cell type, application, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Instruments
• Reagents
• Consumables

Cell Type

• Mammalian Cell
• Bacterial Cell
• Yeast/Algae/Fungi
• Plant Cell

Application

• Protein Isolation
• Downstream Processing
• Cell Organelle Isolation
• Nucleic Acid Isolation

End-User

• Academic and Research Institutes
• Hospitals and Diagnostic Labs
• Cell Banks
• Pharmaceutical and Biotechnology Companies

Cell Lysis and Dissociation Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, product type, cell type, application, and end-user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the cell lysis and dissociation market, driven by substantial government support for molecular biology and cancer research. Increased funding and initiatives aimed at advancing scientific research and developing new therapies are boosting market growth. Additionally, the region's well-established research infrastructure and high level of investment in biotechnology further contribute to its dominance.

The Asia-Pacific region is anticipated to experience the highest growth rate in the cell lysis and dissociation market from 2024 to 2031, driven by a surge in interest from companies expanding their research and development activities in the region. This growth is supported by the rising investment in biotechnology and molecular biology, coupled with the region's rapidly advancing research infrastructure.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.  

세포 용해 및 분리 시장 점유율

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 운영되는 세포 용해 및 분리 시장 리더는 다음과 같습니다.

• 머크 KGaA(독일)
• Bio-Rad Laboratories, Inc. (미국)
• BD(미국)
• Thermo Fisher Scientific Inc. (미국)
• Cell Signaling Technology, Inc. (미국)
• Qsonica(미국)
• Covaris, LLC. (미국)
• Abcam Limited(영국)
• IDEX(미국)
• Claremont BioSolutions, LLC. (미국)
• 밀테니 바이오텍(독일)
• F. 호프만-라 로슈 유한회사(스위스)
• Parr Instrument Company (미국)

세포 용해 및 분리 시장의 최신 개발

• 2024년 7월, 생명 과학 및 첨단 기술 분야에 필수적인 제품과 서비스를 제공하는 세계적 공급업체인 Avantor는 두 가지 획기적인 제품인 New JTBaker Cell Lysis Solution과 JTBaker Endonuclease를 출시했습니다. 이러한 혁신은 유전자 치료 제조업체가 귀중한 바이러스 입자의 품질과 무결성을 유지하면서 수확 프로세스를 개선하는 데 도움이 되도록 설계되었습니다.
• 2021년 1월 Thermo Fisher Scientific, Inc.는 Novasep의 바이러스 벡터 제조 부문인 Henogen SA를 인수했다고 밝혔습니다. 이 인수로 Thermo Fisher의 유전자 및 세포 치료와 백신 역량이 크게 향상되었고, 제조 워크플로 내에서 세포 용해 및 파괴 작업도 향상되었습니다.

SKU-50328